{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:06:36Z","timestamp":1777514796303,"version":"3.51.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>The SARS-CoV-2 pandemic has led to widespread research on associated clinical syndromes. While pediatric patients were initially deemed as a low-risk population for severe COVID-related disease, an increasing number of case reports have revealed a rare but potentially life-threatening syndrome, multisystem inflammatory syndrome in children (MIS-C). MIS-C is hypothesized to be due to hyperactivation of the immune system via a cytokine storm which leads to end-organ damage via endothelial dysfunction and changes in vascular permeability. Laboratory studies have displayed increased inflammatory markers such as C-reactive protein, erythrocyte sedimentation rate, D-dimer, tumor necrosis factor-alpha, and various interleukins. Studies have reported a wide range of clinical manifestations, including but not limited to fever, hypotension, shock, rash, coagulopathy, and gastrointestinal distress. Cardiac imaging and screening tests have revealed several complications, such as left ventricular failure, arrhythmias, and pericardial effusions. Medical management of MIS-C and cardiac sequelae have included supportive care, intravenous immunoglobulins, and corticosteroids, as well as immunomodulators, monoclonal antibodies, aspirin, and therapeutic anticoagulation, which have prevented serious outcomes in the majority of pediatric patients. Future multicenter and large-scale research is required for precise risk-stratification of MIS-C as well as long-term monitoring of sequelae. In this review, we aim to (1) outline the laboratory findings and clinical manifestations of MIS-C, and (2) describe cardiac complications and medical management of MIS-C.<\/jats:p>","DOI":"10.1097\/crd.0000000000000565","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T14:00:22Z","timestamp":1704290422000},"source":"Crossref","is-referenced-by-count":3,"title":["Multisystem Inflammatory Syndrome in Children during the COVID-19 Pandemic: A Review of Clinical Manifestations, Cardiac Complications and Medical Management"],"prefix":"10.1097","author":[{"given":"Maya","family":"Pandit","sequence":"first","affiliation":[{"name":"New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College\/Westchester Medical Center, Valhalla, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"R1-20240103","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1172\/JCI140970","article-title":"Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.","volume":"130","author":"Diorio","year":"2020","journal-title":"J Clin Invest"},{"key":"R2-20240103","doi-asserted-by":"crossref","first-page":"e14471","DOI":"10.1111\/ijcp.14471","article-title":"Algorithm for the diagnosis and management of the multisystem inflammatory syndrome in children associated with COVID-19.","volume":"75","author":"Emeksiz","year":"2021","journal-title":"Int J Clin Pract"},{"key":"R5-20240103","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajem.2021.05.076","article-title":"Multisystem inflammatory syndrome in children with COVID-19.","volume":"49","author":"Gottlieb","year":"2021","journal-title":"Am J Emerg Med"},{"key":"R6-20240103","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents.","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"R7-20240103","doi-asserted-by":"crossref","first-page":"100527","DOI":"10.1016\/j.eclinm.2020.100527","article-title":"Multisystem inflammatory syndrome in children: a systematic review.","volume":"26","author":"Ahmed","year":"20202020","journal-title":"EClinicalMedicine"},{"key":"R8-20240103","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41584-020-00566-y","article-title":"MIS-C: early lessons from immune profiling.","volume":"17","author":"Henderson","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"R9-20240103","doi-asserted-by":"crossref","first-page":"e22997","DOI":"10.1371\/journal.pone.0022997","article-title":"Staphylococcal toxic shock syndrome 2000\u20132006: epidemiology, clinical features, and molecular characteristics.","volume":"6","author":"DeVries","year":"2011","journal-title":"PLoS One"},{"key":"R10-20240103","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2606.190783","article-title":"Manifestations of toxic shock syndrome in children, Columbus, Ohio, USA, 2010\u20132017.","volume":"26","author":"Cook","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"R12-20240103","doi-asserted-by":"crossref","first-page":"25254","DOI":"10.1073\/pnas.2010722117","article-title":"Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.","volume":"117","author":"Cheng","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-20240103","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00381-020-04784-3","article-title":"Tomisaku Kawasaki and Kawasaki disease.","volume":"38","author":"Yale","year":"2022","journal-title":"Childs Nerv Syst"},{"key":"R14-20240103","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association.","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"R15-20240103","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARSCoV-2 epidemic: an observational cohort study.","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"key":"R16-20240103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00296-020-04749-4","article-title":"Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.","volume":"41","author":"Kabeerdoss","year":"2021","journal-title":"Rheumatol Int"},{"key":"R17-20240103","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jama.2021.2091","article-title":"Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS- C) compared with severe acute COVID-19.","volume":"325","author":"Feldstein","year":"2021","journal-title":"JAMA"},{"key":"R18-20240103","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/CRD.0000000000000341","article-title":"Myocarditis in multisystem inflammatory syndrome in children associated with coronavirus disease 2019.","volume":"28","author":"Jain","year":"2020","journal-title":"Cardiol Rev"},{"key":"R19-20240103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-021-01602-3","article-title":"Cardiac manifestations of multisystem inflammatory syndrome in children (MIS-C) following COVID-19.","volume":"23","author":"Wu","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"R20-20240103","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.120.049836","article-title":"Review of cardiac involvement in multisystem inflammatory syndrome in children.","volume":"143","author":"Alsaied","year":"2021","journal-title":"Circulation"},{"key":"R21-20240103","first-page":"5518979","article-title":"Cardiac manifestations in COVID-19 patients: a focus on the pediatric population.","volume":"2021","author":"Abi","year":"2021","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R22-20240103","first-page":"1294846","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"R23-20240103","doi-asserted-by":"crossref","first-page":"e2020009704","DOI":"10.1542\/peds.2020-009704","article-title":"Atrioventricular block in children with multisystem inflammatory syndrome.","volume":"146","author":"Dionne","year":"2020","journal-title":"Pediatrics"},{"key":"R24-20240103","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCULATIONAHA.120.048360","article-title":"Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic.","volume":"142","author":"Belhadjer","year":"2020","journal-title":"Circulation"},{"key":"R25-20240103","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.echo.2020.08.008","article-title":"Multisystem inflammatory syndrome in children: cardiac biomarker profiles and echocardiographic findings in the acute and recovery phases.","volume":"33","author":"Kelly","year":"2020","journal-title":"J Am Soc Echocardiogr"},{"key":"R26-20240103","doi-asserted-by":"crossref","first-page":"e2020009738","DOI":"10.1542\/peds.2020-009738","article-title":"MIS-C and cardiac conduction abnormalities.","volume":"146","author":"Choi","year":"2020","journal-title":"Pediatrics"},{"key":"R27-20240103","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ped4.12232","article-title":"Complexities of the COVID-19 vaccine and multisystem inflammatory syndrome in children.","volume":"4","author":"Blumenthal","year":"2020","journal-title":"Pediatr Investig"},{"key":"R28-20240103","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1002\/art.41616","article-title":"American College of rheumatology clinical guidance for multisystem inflammatory syndrome in children associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: version 2.","volume":"73","author":"Henderson","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R29-20240103","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa2117995","article-title":"Effectiveness of BNT162b2 vaccine against critical Covid-19 in adolescents.","volume":"386","author":"Olson","year":"2022","journal-title":"N Engl J Med"},{"key":"R30-20240103","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.2021.23262","article-title":"Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France.","volume":"327","author":"Levy","year":"2022","journal-title":"JAMA"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T14:00:33Z","timestamp":1704290433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000565","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,3]]}}}